Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Thomas

Showing results (291-300 of 333) with videos related to

Pageof 34
Sort By:
Health Technology Assessment (Winchester, England)|April 15, 2022
Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCTJonathan R Benger, Kim Kirby, Sarah Black, et al.
Interventional Cardiology (London, England)|January 12, 2024
Validation of the MIRACLE<sub>2</sub> Score for Prognostication After Out-of-hospital Cardiac ArrestNicholas Sunderland, Francine Cheese, Zoe Leadbetter, et al.
Intensive Care Medicine|April 28, 2025
Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trialAkil Awad, Martin Jonsson, Johan Holgersson, et al.
Journal of Medicinal Chemistry|August 12, 2021
Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γBenjamin R Bellenie, Edward Hall, Ian Bruce, et al.
Resuscitation|June 14, 2021
Cost-effectiveness of the i-gel supraglottic airway device compared to tracheal intubation during out-of-hospital cardiac arrest: Findings from the AIRWAYS-2 randomised controlled trialElizabeth A Stokes, Michelle J Lazaroo, Madeleine Clout, et al.
Journal of Medicinal Chemistry|June 1, 2018
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ InhibitorsNils Pemberton, Mickael Mogemark, Susanne Arlbrandt, et al.
Resuscitation Plus|July 31, 2023
Randomised trial of the clinical and cost effectiveness of a supraglottic airway device compared with tracheal intubation for in-hospital cardiac arrest (AIRWAYS-3): Protocol, design and implementationScott Watkins, Fatimah J Chowdhury, Chloe Norman, et al.
Frontiers in Pharmacology|May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related HydroxylasesMike Petrassi, Rob Barber, Celine Be, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 23, 2012
Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1AIan M Campbell, Svetlana A Yatsenko, Patricia Hixson, et al.
BMJ Open|March 4, 2022
Ventilation management and outcomes in out-of-hospital cardiac arrest: a protocol for a preplanned secondary analysis of the TTM2 trialChiara Robba, Niklas Nielsen, Josef Dankiewicz, et al.
Pageof 34

Showing results (291-300 of 333) with videos related to

Sort By:
Pageof 34
Health Technology Assessment (Winchester, England)|April 15, 2022
Supraglottic airway device versus tracheal intubation in the initial airway management of out-of-hospital cardiac arrest: the AIRWAYS-2 cluster RCTJonathan R Benger, Kim Kirby, Sarah Black, et al.
Interventional Cardiology (London, England)|January 12, 2024
Validation of the MIRACLE<sub>2</sub> Score for Prognostication After Out-of-hospital Cardiac ArrestNicholas Sunderland, Francine Cheese, Zoe Leadbetter, et al.
Intensive Care Medicine|April 28, 2025
Intravascular vs. surface cooling in out-of-hospital cardiac arrest patients receiving hypothermia after hospital arrival: a post hoc analysis of the TTM2 trialAkil Awad, Martin Jonsson, Johan Holgersson, et al.
Journal of Medicinal Chemistry|August 12, 2021
Discovery and Toxicological Profiling of Aminopyridines as Orally Bioavailable Selective Inhibitors of PI3-Kinase γBenjamin R Bellenie, Edward Hall, Ian Bruce, et al.
Resuscitation|June 14, 2021
Cost-effectiveness of the i-gel supraglottic airway device compared to tracheal intubation during out-of-hospital cardiac arrest: Findings from the AIRWAYS-2 randomised controlled trialElizabeth A Stokes, Michelle J Lazaroo, Madeleine Clout, et al.
Journal of Medicinal Chemistry|June 1, 2018
Discovery of Highly Isoform Selective Orally Bioavailable Phosphoinositide 3-Kinase (PI3K)-γ InhibitorsNils Pemberton, Mickael Mogemark, Susanne Arlbrandt, et al.
Resuscitation Plus|July 31, 2023
Randomised trial of the clinical and cost effectiveness of a supraglottic airway device compared with tracheal intubation for in-hospital cardiac arrest (AIRWAYS-3): Protocol, design and implementationScott Watkins, Fatimah J Chowdhury, Chloe Norman, et al.
Frontiers in Pharmacology|May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related HydroxylasesMike Petrassi, Rob Barber, Celine Be, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 23, 2012
Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1AIan M Campbell, Svetlana A Yatsenko, Patricia Hixson, et al.
BMJ Open|March 4, 2022
Ventilation management and outcomes in out-of-hospital cardiac arrest: a protocol for a preplanned secondary analysis of the TTM2 trialChiara Robba, Niklas Nielsen, Josef Dankiewicz, et al.
Pageof 34